Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Primary Central Nervous System Lymphoma
Related studies linked through entity extraction aliases.
Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Orelabrutinib Maintenance Therapy After ASCT in Primary Central Nervous System Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
A Dose-escalating Pilot Study of Orelabrutinib for Newly-diagnosed PCNSL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Rituximab,Methotrexate and Lenalidomide in Newly Diagnosed Primary Central Nervous System Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Orelabrutinib Combined With PD-1 Inhibitor in Relapsed/Refractory Primary Central Nervous System Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Case Study of Nivolumab for Relapsed/Refractory Primary Central Nervous System Lymphoma
- Status
- UNKNOWN
- Phase
- NA
A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Rituximab, Lenalidomide Combined With Methotrexate and Temozolomide For Primary Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL)
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab, Ibrutinib and Rituximab in PCNSL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL：a Multicenter Phase Ib/II Stuty
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE4
Camrelizumab for Patients with Recurrent Primary Central Nervous System Lymphoma (PCNSL)
- Status
- RECRUITING
- Phase
- PHASE2